Search | IOVS | ARVO Journals

Showing 1 – 20 of 33

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Imaging in the Eye Conference Abstract July 2020

Spatial distribution of scotopic versus mesopic microperimetry detection thresholds in ABCA4-related Stargardt disease – the ProgStar-SMART study

Ahmed F Shakarchi; Xiangrong Kong

Invest. Ophthalmol. Vis. Sci.. 2020; 61(9):PB0059. doi:

ARVO Annual Meeting Abstract June 2020

Macular function response to N-acetylcysteine Treatment in patients with Retinitis Pigmentosa

Grace Tsai; Peter A Campochiaro; Xiangrong Kong

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1909. doi:

ARVO Annual Meeting Abstract June 2020

Measuring progression at the edge of dense macular scotomas in Stargardt disease

Etienne Schönbach; Rupert Strauss; Mohamed I. Ahmed; Jessica Janes; David G Birch; Artur Cideciyan; Janet Sunness; Xiangrong Kong; Beatriz E Munoz; Michael S Ip; Srinivas Sadda; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3189. doi:

ARVO Annual Meeting Abstract June 2020

Image Quality and Retinal Vascular Metrics in the Community using Optical Coherence Tomography Angiography

Saleema A. Kherani; Xinxing Guo; Lubaina Arsiwala; Yanan Dong; Xiangrong Kong; A. Richey Sharrett; Pradeep Y Ramulu; David Huang; Brandon J Lujan; Alexander Tomlinson; Alison Abraham

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1606. doi:

ARVO Annual Meeting Abstract July 2019

Moving Beyond Visual Acuity: Examining associations between visual acuity, contrast sensitivity, and cognition in an older adult population

Elizabeth Couser; Xiangrong Kong; Richey Sharrett; Xinxing Guo; Pradeep Y Ramulu; Bonnielin K Swenor; Alison Abraham

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5916. doi:

ARVO Annual Meeting Abstract July 2019

Using retinal structural measurements derived from optical coherence tomography as clinical endpoints for Stargardt disease - reproducibility assessment and lessons learned from the ProgStar study

Xiangrong Kong; Alexander Ho; Beatriz Munoz; Sheila K West; Rupert W Strauss; Anamika Jha; Ann Margret Ervin; Janet Cheetham; Michael S Ip; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3945. doi:

ARVO Annual Meeting Abstract July 2019

Retinal microvascular health and what it tells us about cognitive function: the Eye Determinants of Cognition (EyeDOC) Study

Alison Abraham; Xinxing Guo; Xiangrong Kong; Richey Sharrett; David Huang; Pradeep Y Ramulu

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4561. doi:

ARVO Annual Meeting Abstract July 2019

Intergrader reproducibility of peripapillary retinal metrics from optical coherence tomographic angiography in community dwelling older adults

Saleema Kherani; Richey Sharrett; Xinxing Guo; Qisheng You; Liang Liu; David Huang; Pradeep Y Ramulu; Alison Abraham; Xiangrong Kong

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):151. doi:

ARVO Annual Meeting Abstract July 2019

Association of OCT structural measures and Axial length with cognitive ability in a biracial sample of non-demented adults

Pradeep Y Ramulu; Xinxing Guo; Xiangrong Kong; David Huang; Richey Sharrett; Alison Abraham

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1837. doi:

ARVO Annual Meeting Abstract July 2019

Retina Structural Features by Optical Coherence Tomography in a Bi-Community Population: the Eye Determinant of Cognition (EyeDOC) Study

Xinxing Guo; Xiangrong Kong; Richey Sharrett; Pradeep Y Ramulu; Alison Abraham

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3953. doi:

Articles June 2019

Reproducibility of Measurements of Retinal Structural Parameters Using Optical Coherence Tomography in Stargardt Disease

PDF

Xiangrong Kong; Alexander Ho; Beatriz Munoz; Sheila West; Rupert W. Strauss; Anamika Jha; Ann Ervin; Jeff Buzas; Mandeep Singh; Zhihong Hu; Janet Cheetham; Michael Ip; Hendrik P. N. Scholl
TAGS: optical coherence tomography, retina, spectral domain-optical coherence tomography, stargardt's disease, atrophy, eye, surrogate endpoints
Trans. Vis. Sci. Tech.. 2019; 8(3):46. doi: https://doi.org/10.1167/tvst.8.3.46

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2018

Initial Quality Control Assessment of Optical Coherence Tomography Angiography Data in the EyeDOC Study

Brandon J Lujan; Alexander Tomlinson; Bilal Hasan; James Carroll; Guo Xinxing; Xiangrong Kong; Laura R Erker; Yali Jia; David Huang; David J Wilson; Pradeep Y Ramulu; Alison Abraham

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2849. doi:

ARVO Annual Meeting Abstract July 2018

Visual function and ocular pathology in an aging bi-racial population sample

Alison Abraham; Xiangrong Kong; Xinxing Guo; Moon Jeong Lee; Pradeep Y Ramulu

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4105. doi:

ARVO Annual Meeting Abstract July 2018

Assessment of visual impairment and eye diseases in HIV-infected people in the ART era in Rakai, Uganda

Xiangrong Kong; Stephanie Irwin; Joseph Ssekasanvu; Beatriz E Munoz; Sheila K West; Gertrude Nakigozi

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4108. doi:

ARVO Annual Meeting Abstract July 2018

Progression of Stargardt disease as measured by spectral-domain optical coherence tomography (SD-OCT) in the ProgStar Study

Rupert Wolfgang Strauss; Xiangrong Kong; Beatriz E Munoz; Sheila K West; Michael S Ip; Alexander Ho; Anamika Jha; Paul S Bernstein; David G Birch; Artur V Cideciyan; Michel Michaelides; José-Alain Sahel; Janet S Sunness; Elias I Traboulsi; Eberhart Zrenner; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1568. doi:

Articles April 2018

Predicting Visual Disability in Glaucoma With Combinations of Vision Measures

PDF

Stephanie Lin; Aleksandra Mihailovic; Sheila K. West; Chris A. Johnson; David S. Friedman; Xiangrong Kong; Pradeep Y. Ramulu
TAGS: disability, glaucoma, vision, vision tests
Trans. Vis. Sci. Tech.. 2018; 7(2):22. doi: https://doi.org/10.1167/tvst.7.2.22

Special Issue September 2017

Metrics and Acquisition Modes for Fixation Stability as a Visual Function Biomarker

PDF

Etienne M. Schönbach; Mohamed A. Ibrahim; Xiangrong Kong; Rupert W. Strauss; Beatriz Muñoz; David G. Birch; Janet S. Sunness; Sheila K. West; Hendrik P. N. Scholl
TAGS: biological markers, stargardt's disease, vision, visual acuity, eye
Invest. Ophthalmol. Vis. Sci.. 2017; 58(6):BIO268-BIO276. doi: https://doi.org/10.1167/iovs.17-21710

ARVO Annual Meeting Abstract June 2017

Natural progression of scotopic and photopic macular function loss in patients with Stargardt disease: The SMART Study.

Millena Bittencourt; Mohamed A Ibrahim; Xiangrong Kong; Rupert Wolfgang Strauss; Ann-Margret Ervin; Alexander Ho; Muneeswar Gupta Nittala; Isabelle S Audo; David G Birch; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3281. doi:

ARVO Annual Meeting Abstract June 2017

Visual acuity loss during two years in Stargardt Disease: The ProgStar Study

Xiangrong Kong; Rupert Wolfgang Strauss; Beatriz Munoz; Ann-Margret Ervin; Artur V Cideciyan; Michel Michaelides; Mohamed Ahmed; Janet Cheetham; Sheila West; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4647. doi:

ARVO Annual Meeting Abstract June 2017

Progression of Atrophic Lesions Determined by Fundus Autofluorescence: The Natural History of the Progression of Atrophy secondary to Stargardt Disease (ProgStar) Study

Rupert Wolfgang Strauss; Xiangrong Kong; Alex Ho; Anamika Jha; Michel Michaelides; Artur V Cideciyan; Jose Alain Sahel; David G Birch; Amir H Hariri; Srinivas R Sadda; Sheila West; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2013. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Spatial distribution of scotopic versus mesopic microperimetry detection thresholds in ABCA4-related Stargardt disease – the ProgStar-SMART study

Macular function response to N-acetylcysteine Treatment in patients with Retinitis Pigmentosa

Measuring progression at the edge of dense macular scotomas in Stargardt disease

Image Quality and Retinal Vascular Metrics in the Community using Optical Coherence Tomography Angiography

Moving Beyond Visual Acuity: Examining associations between visual acuity, contrast sensitivity, and cognition in an older adult population

Using retinal structural measurements derived from optical coherence tomography as clinical endpoints for Stargardt disease - reproducibility assessment and lessons learned from the ProgStar study

Retinal microvascular health and what it tells us about cognitive function: the Eye Determinants of Cognition (EyeDOC) Study

Intergrader reproducibility of peripapillary retinal metrics from optical coherence tomographic angiography in community dwelling older adults

Association of OCT structural measures and Axial length with cognitive ability in a biracial sample of non-demented adults

Retina Structural Features by Optical Coherence Tomography in a Bi-Community Population: the Eye Determinant of Cognition (EyeDOC) Study

Reproducibility of Measurements of Retinal Structural Parameters Using Optical Coherence Tomography in Stargardt Disease

Initial Quality Control Assessment of Optical Coherence Tomography Angiography Data in the EyeDOC Study

Visual function and ocular pathology in an aging bi-racial population sample

Assessment of visual impairment and eye diseases in HIV-infected people in the ART era in Rakai, Uganda

Progression of Stargardt disease as measured by spectral-domain optical coherence tomography (SD-OCT) in the ProgStar Study

Predicting Visual Disability in Glaucoma With Combinations of Vision Measures

Metrics and Acquisition Modes for Fixation Stability as a Visual Function Biomarker

Natural progression of scotopic and photopic macular function loss in patients with Stargardt disease: The SMART Study.

Visual acuity loss during two years in Stargardt Disease: The ProgStar Study

Progression of Atrophic Lesions Determined by Fundus Autofluorescence: The Natural History of the Progression of Atrophy secondary to Stargardt Disease (ProgStar) Study

To View More...

You must be signed into an individual account to use this feature.